However, we might also take into account the potential influence on the phenotypic expression of the SCA6 pathological CAG expansion in such patients of other coexisting pathogenic variants or polymorphisms in PD related genes considered as risk factors. The gene discussed is CACNA1A; the disease is Parkinson disease.